Abstract
Background/Objectives
Patients colonized with toxinogenic strains of Clostridium difficile have an increased risk of subsequent infection. Given the potential role of the gut microbiome in increasing the risk of C. difficile colonization, we assessed the diversity and composition of the gut microbiota among long-term care facility (LTCF) residents with advanced dementia colonized with C. difficile.
Design
Retrospective analysis of rectal samples collected during a prospective observational study.
Setting
Thirty-five nursing homes in Boston, Massachusetts.
Participants
Eighty-seven LTCF residents with advanced dementia.
Measurements
Operational taxonomic units were identified using 16S rRNA sequencing. Samples positive for C. difficile were matched to negative controls in a 1:3 ratio and assessed for differences in alpha diversity, beta diversity, and differentially abundant features.
Results
Clostridium difficile sequence variants were identified among 7/87 (8.04%) residents. No patient had evidence of C. difficile infection. Demographic characteristics and antimicrobial exposure were similar between the seven cases and 21 controls. The overall biodiversity among cases and controls was reduced with a median Shannon index of 3.2 (interquartile range 2.7–3.9), with no statistically significant differences between groups. The bacterial community structure was significantly different among residents with C. difficile colonization versus those without and included a predominance of Akkermansia spp., Dermabacter spp., Romboutsia spp., Meiothermus spp., Peptoclostridium spp., and Ruminococcaceae UGC 009.
Conclusion
LTCF residents with advanced dementia have substantial dysbiosis of their gut microbiome. Specific taxa characterized C. difficile colonization status.




Similar content being viewed by others
References
Clostridium difficile infection in 2015. Centers for Disease Control and Prevention (CDC). Available at: https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html. Accessed July 3, 2017.
Antimicrobial resistance. Centers for Disease Control and Prevention (CDC). Available at: https://www.cdc.gov/drugresistance/biggest_threats.html. Accessed July 3, 2017.
Ziakas PD, Joyce N, Zacharioudakis IM, et al. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: a nationwide study. Medicine (Baltimore). 2016;95:e4187.
Karanika S, Grigoras C, Flokas ME, et al. The attributable burden of Clostridium difficile infection to long-term care facilities stay: a Clinical Study. J Am Geriatr Soc. 2017;65:1733–1740.
Ziakas PD, Zacharioudakis IM, Zervou FN, et al. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS ONE. 2015;10:e0117195.
Vincent C, Manges AR. Antimicrobial use, human gut microbiota and Clostridium difficile colonization and infection. Antibiotics (Basel). 2015;4:230–253.
Theriot CM, Young VB. Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu Rev Microbiol. 2015;69:445–461.
Manges AR, Labbe A, Loo VG, et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis. 2010;202:1877–1884.
Vincent C, Stephens DA, Loo VG, et al. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome. 2013;1:18.
Girotra M, Garg S, Anand R, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection in the elderly: long-Term outcomes and microbiota changes. Dig Dis Sci. 2016;61:3007–3015.
Seekatz AM, Aas J, Gessert CE, et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio. 2014;5:e00893-00814.
Zacharioudakis IM, Zervou FN, Pliakos EE, et al. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:381–390. (quiz 391).
Mitchell SL, Shaffer ML, Kiely DK, et al. The study of pathogen resistance and antimicrobial use in dementia: study design and methodology. Arch Gerontol Geriatr. 2013;56:16–22.
Mitchell SL, Shaffer ML, Loeb MB, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174:1660–1667.
Volicer L, Hurley AC, Lathi DC, et al. Measurement of severity in advanced Alzheimer’s disease. J Gerontol. 1994;49:M223–M226.
Albert M, Cohen C. The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc. 1992;40:449–453.
Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336.
Iizumi T, Taniguchi T, Yamazaki W, et al. Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 2016;8:60.
Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–583.
McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8:e61217.
Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
Mitchell SL. Advanced dementia. N Engl J Med. 2015;373:1276–1277.
Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178–184.
Lewis BB, Pamer EG. Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections. Annu Rev Microbiol. 2017;71:157–178.
Antharam VC, Li EC, Ishmael A, et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51:2884–2892.
Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279:90–105.
D’Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med. 2008;168:357–362.
Lee YJ, Arguello ES, Jenq RR, et al. Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2017;215:1117–1123.
Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1–11.
Schubert AM, Rogers MA, Ring C, et al. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio. 2014;5:e01021-01014.
Zhang L, Dong D, Jiang C, et al. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Anaerobe. 2015;34:1–7.
Milani C, Ticinesi A, Gerritsen J, et al. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study. Sci Rep. 2016;6:25945.
Rea MC, O’Sullivan O, Shanahan F, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50:867–875.
Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197:435–438.
Bassis CM, Moore NM, Lolans K, et al. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol. 2017;17:78.
Budding AE, Grasman ME, Eck A, et al. Rectal swabs for analysis of the intestinal microbiota. PLoS ONE. 2014;9:e101344.
Funding
This work has been supported by the National Institute of Allergy and Infectious Diseases (K24 AI119158 [EMCD]), the Centers for Disease Control and Prevention’s investments to combat antibiotic resistance under Award Number 200-2016-91939 (EMCD and RA), NIH-NIA R01 AG032982 (SM, EMCD), and NIH-NIA K24AG033640 (SM).
Author information
Authors and Affiliations
Contributions
Dr. D’Agata and Araos contributed to the study concept and design, acquisition of subjects, and collection of the relevant data. Dr. Araos, Ugalde, and D’Agata performed the data analysis. All authors contributed to data interpretation and collaborated on the drafting and revision of the manuscript. Dr. Araos is the guarantor and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
Conflict of interest
Juan Ugalde is an employee of uBiome Inc and has received stock options as well as other compensation.
Rights and permissions
About this article
Cite this article
Araos, R., Andreatos, N., Ugalde, J. et al. Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile. Dig Dis Sci 63, 1525–1531 (2018). https://doi.org/10.1007/s10620-018-5030-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5030-7